Home	Fast Track My Amedeo FAQ About	Flying Publisher
Fast Track	FPG #8: Alternative Treatments in Psychiatry FPG #7: Critical Care in Neurology	Free Medical Books

Leukemia

Free Subscription Articles published in Exp Hematol Retrieve available abstracts of 50 articles: HTML format Text format

Single Articles

January 2012
1. AIRIAU K , Mahon FX, Josselin M, Jeanneteau M, et al
   ABT-737 increases tyrosine kinase inhibitor-induced apoptosis in chronic myeloid leukemia cells through XIAP down-regulation and sensitizes CD34+ CD38- population to imatinib.
   Exp Hematol. 2012.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
2. SU W , Meng F, Huang L, Zheng M, et al
   Sonic hedgehog maintains survival and growth of chronic myeloid leukemia progenitor cells through beta-catenin signaling.
   Exp Hematol. 2012.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
3. MILONE G , Avola G, Leotta S, Strano A, et al
   Chemosensitivity of nonleukemic clonogenic precursors in AML patients in complete remission: association with CD34(+) mobilization and with disease-free survival.
   Exp Hematol. 2012;40:35-47.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
4. CUI XY , Wang N, Yang BX, Gao WF, et al
   HSPB8 is methylated in hematopoietic malignancies and overexpression of HSPB8 exhibits antileukemia effect.
   Exp Hematol. 2012;40:14-21.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   November 2011
5. BACALINI MG , Tavolaro S, Peragine N, Marinelli M, et al
   A subset of chronic lymphocytic leukemia (CLL) patients displays reduced levels of PARP1 expression coupled to a defective irradiation-induced apoptosis.
   Exp Hematol. 2011.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
6. KHAN NI , Cisterne A, Baraz R, Bradstock KF, et al
   Para-NO-Aspirin inhibits NF-kappaB and induces apoptosis in B-cell progenitor acute lymphoblastic leukemia.
   Exp Hematol. 2011.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
7. TAKEI F
   LAK cell therapy of AML: not to be lost in translation.
   Exp Hematol. 2011;39:1045-6.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
8. FRIKECHE J , Clavert A, Delaunay J, Brissot E, et al
   Impact of the hypomethylating agent 5-azacytidine on dendritic cells function.
   Exp Hematol. 2011;39:1056-63.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
9. LARSEN HO , Roug AS, Nielsen K, Sondergaard CS, et al
   Nonviral transfection of leukemic primary cells and cells lines by siRNA-a direct comparison between Nucleofection and Accell delivery.
   Exp Hematol. 2011;39:1081-9.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   October 2011
10. RAN D , Schubert M, Taubert I, Eckstein V, et al
    Heterogeneity of leukemia stem cell candidates at diagnosis of acute myeloid leukemia and their clinical significance.
    Exp Hematol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
11. WILSON NK , Tijssen MR, Gottgens B
    Deciphering transcriptional control mechanisms in hematopoiesis:the impact of high-throughput sequencing technologies.
    Exp Hematol. 2011;39:961-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    September 2011
12. BORSSEN M , Cullman I, Noren-Nystrom U, Sundstrom C, et al
    hTERT promoter methylation and telomere length in childhood acute lymphoblastic leukemia - associations with immunophenotype and cytogenetic subgroup.
    Exp Hematol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
13. KUNTER G , Woloszynek JR, Link DC
    A truncation mutant of Csf3r cooperates with PML-RARalpha to induce acute myeloid leukemia in mice.
    Exp Hematol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
14. SHIVTIEL S , Lapid K, Kalchenko V, Avigdor A, et al
    CD45 regulates homing and engraftment of immature normal and leukemic human cells in transplanted immunodeficient mice.
    Exp Hematol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
15. YAMAZAKI R , Nakasone H, Wada H, Sakamoto K, et al
    Recurrence of monoclonal gammopathy associated with donor-derived myelodysplastic syndrome after cord blood stem cell transplantation.
    Exp Hematol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    August 2011
16. MOGA E , Canto E, Vidal S, Juarez C, et al
    Interleukin-15 enhances rituximab-dependent cytotoxicity against chronic lymphocytic leukemia cells and overcomes transforming growth factor beta-mediated immunosupression.
    Exp Hematol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    July 2011
17. OVCHARENKO D , Stolzel F, Poitz D, Fierro F, et al
    miR-10a Overexpression is Associated with NPM1 Mutations and Mdm4 Downregulation in Intermediate-Risk Acute Myeloid Leukemia.
    Exp Hematol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
18. LIM JY , Choi MS, Youn H, Choi EY, et al
    The influence of pre-transplant conditioning on graft-versus-leukemia effect in mice.
    Exp Hematol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    June 2011
19. NIAM M , Linn YC, Chong SF, Lim TJ, et al
    Clinical scale expansion of Cytokine-Induced Killer Cells is feasible from healthy donors and patients with acute and chronic myeloid leukemia at various stages of therapy.
    Exp Hematol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    April 2011
20. KIM HP , Gerhard B, Harasym TO, Mayer LD, et al
    Liposomal encapsulation of a synergistic molar ratio of cytarabine and daunorubicin enhances selective toxicity for acute myeloid leukemia progenitors as compared to analogous normal hematopoietic cells.
    Exp Hematol. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
21. PARDEE TS , Zuber J, Lowe SW
    Flt3-ITD alters chemotherapy response in vitro and in vivo in a p53-dependent manner.
    Exp Hematol. 2011;39:473-485.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    March 2011
22. SCHILDGEN V , Wulfert M, Gattermann N
    Impaired mitochondrial gene transcription in myelodysplastic syndromes and acute myeloid leukemia with myelodysplasia-related changes.
    Exp Hematol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
23. MARFE G , Di Stefano C, Gambacurta A, Ottone T, et al
    Sphingosine Kinase I overexpression is regulated by signaling through PI3K, AKT2, and mTOR in Imatinib-Resistant Chronic Myeloid Leukemia (CML) cells.
    Exp Hematol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
24. HUMPHRIES RK
    Exciting times for our field and the Journal.
    Exp Hematol. 2011;39:271.
    PubMed     Text format     Related articles   
    
    
    
    February 2011
25. SCHUBERT M , Herbert N, Taubert I, Ran D, et al
    Differential survival of AML subpopulations in NOD/SCID mice.
    Exp Hematol. 2011;39:250-263.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
26. CAPRARO V , Zane L, Poncet D, Perol D, et al
    Telomere deregulations possess cytogenetic, phenotype, and prognostic specificities in acute leukemias.
    Exp Hematol. 2011;39:195-202.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    January 2011
27. BATISTA A , Barata JT, Raderschall E, Sallan SE, et al
    Targeting of active mtor inhibits primary leukemia t-cells and synergizes with cytotoxic drugs and signaling inhibitors.
    Exp Hematol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
28. KITAWAKI T , Kadowaki N, Fukunaga K, Kasai Y, et al
    Cross-priming of CD8(+) T cells in vivo by dendritic cells pulsed with autologous apoptotic leukemic cells in immunotherapy for elderly patients with acute myeloid leukemia.
    Exp Hematol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
29. BRASSAT U , Balabanov S, Bali D, Dierlamm J, et al
    Functional p53 is required for effective execution of telomerase inhibition in BCR-ABL-positive CML cells.
    Exp Hematol. 2011;39:66-76.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
30. SCHNITTGER S , Bacher U, Eder C, Lohse P, et al
    A copy number repeat polymorphism in the transactivation domain of the CEPBA gene is possibly associated with a protective effect against acquired CEBPA mutations: an analysis in 1135 patients with AML and 187 healthy controls.
    Exp Hematol. 2011;39:87-94.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    December 2010
31. BEIDER K , Begin M, Abraham M, Wald H, et al
    The CXCR4 Antagonist 4F-benzoyl-TN14003 Inhibits Leukemia and Multiple Myeloma Tumor Growth.
    Exp Hematol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
32. JIANG N , Koh GS, Suang Lim JY, Yin Kham SK, et al
    BIM is a prognostic biomarker for early prednisolone response in pediatric acute lymphoblastic leukemia (ALL).
    Exp Hematol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
33. ROJAS JM , Wang L, Owen S, Knight K, et al
    Naturally occurring CD4+ CD25+ FOXP3+ T-regulatory cells are increased in chronic myeloid leukemia patients not in complete cytogenetic remission and can be immunosuppressive.
    Exp Hematol. 2010;38:1209-18.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    November 2010
34. BIGILDEEV AE , Shipounova IN, Svinareva DA, Driz NJ, et al
    Leukaemia cells invading the liver express liver chemokine receptors and possess characteristics of leukaemia stem cells in mice with MPD-like myeloid leukaemia.
    Exp Hematol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
35. ANDO K , Miyazaki Y, Sawayama Y, Tominaga S, et al
    High expression of 67 kDa laminin receptor relates to the proliferation of leukemia cells and increases the expression of GM-CSF receptor.
    Exp Hematol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
36. GLADKIKH A , Potashnikova D, Korneva E, Khudoleeva O, et al
    Cyclin D1 expression in B-cell lymphomas.
    Exp Hematol. 2010;38:1047-57.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
37. DEBRUIN C , Lincoln P, Hartley C, Shehabeldin A, et al
    Most purported antibodies to the human granulocyte colony-stimulating factor receptor are not specific.
    Exp Hematol. 2010;38:1022-35.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
38. WANG X , Schmitt A, Chen B, Xu X, et al
    Streptamer-based selection of WT1-specific CD8+ T cells for specific donor lymphocyte infusions.
    Exp Hematol. 2010;38:1066-73.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    October 2010
39. IMREN S , Zhang XB, Humphries RK, Kiem HP, et al
    Insights into leukemia initiating cell frequency and self-renewal from a novel canine model of leukemia.
    Exp Hematol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    September 2010
40. JALKANEN S , Vakkila J, Kreutzman A, Nieminen J, et al
    Poor cytokine induced phosphorylation in chronic myeloid leukemia patients at diagnosis is effectively reversed by tyrosine kinase inhibitor therapy.
    Exp Hematol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
41. MONROE SC , Jo SY, Sanders DS, Basrur V, et al
    MLL-AF9 and MLL-ENL alter the dynamic association of transcriptional regulators with genes critical for leukemia.
    Exp Hematol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
42. WIEDEMANN B , Klyuchnikov E, Kroger N, Zabelina T, et al
    Chimerism studies with quantitative real-time PCR in stem cell recipients with acute myeloid leukemia (AML).
    Exp Hematol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
43. SKRIBEK H , Otvos R, Flaberg E, Nagy N, et al
    Chronic lymphoid leukemia cells are highly sensitive to the combination of prednisolon and daunorubicin but much less to doxorubicin or epirubicin.
    Exp Hematol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
44. FISHEL ML , Colvin ES, Luo M, Kelley MR, et al
    Inhibition of the Redox Function of APE1/Ref-1 in Myeloid Leukemia Cell Lines Results in a Hypersensitive Response to Retinoic Acid-induced Differentiation and Apoptosis.
    Exp Hematol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
45. DANILOV AV , Danilova OV, Brown JR, Rabinowitz A, et al
    Dipeptidyl Peptidase 2 apoptosis assay determines the B-cell activation stage and predicts prognosis in chronic lymphocytic leukemia.
    Exp Hematol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
46. XIANG P , Lo C, Argiropoulos B, Lai CB, et al
    Identification of E74-like factor 1 (ELF1) as a transcriptional regulator of the Hox cofactor MEIS1.
    Exp Hematol. 2010;38:798-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
47. AKERS SM , O'Leary HA, Minnear FL, Craig MD, et al
    VE-cadherin and PECAM-1 enhance ALL migration across brain microvascular endothelial cell monolayers.
    Exp Hematol. 2010;38:733-43.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    August 2010
48. ZOPPOLI G , Cea M, Soncini D, Fruscione F, et al
    Potent synergistic interaction between the Nampt inhibitor APO866 and the apoptosis activator TRAIL in human leukemia cells.
    Exp Hematol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
49. YANG J , Ikezoe T, Nishioka C, Ni L, et al
    Inhibition of mTORC1 by RAD001 (everolimus) potentiates the effects of 1,25-dihydroxyvitamin D(3) to induce growth arrest and differentiation of AML cells in vitro and in vivo.
    Exp Hematol. 2010;38:666-76.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    July 2010
50. AKAHANE K , Inukai T, Zhang X, Hirose K, et al
    Resistance of T-cell acute lymphoblastic leukemia (T-ALL) to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-mediated apoptosis.
    Exp Hematol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    

Thank you for your interest in scientific medicine.

Amedeo is a Flying Publisher website.    Design: